Effects of leukotriene receptor antagonists on peripheral eosinophil counts and serum IgE levels in children with food allergy

Drugs in R and D

Volumn 10, Issue 3, 2010, Pages 147-154

  Yamakawa, Yoko ^a   Ohtsuka, Yoshikazu ^a   Ohtani, Kiyotaka ^a   Fujii, Tohru ^a   Nagata, Satoru ^a   Yamashiro, Yuichiro ^a   Shimizu, Toshiaki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Children; Food hypersensitivity; Infants; Pranlukast; therapeutic use; treatment

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PRANLUKAST; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CHILD; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFICACY; EOSINOPHIL COUNT; FEMALE; FOOD ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

CHILD, PRESCHOOL; CHROMONES; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; INFANT; INTERLEUKINS; LEUKOCYTE COUNT; LEUKOTRIENE ANTAGONISTS; MALE;

EID: 79953217395     PISSN: 11745886     EISSN: 11796901     Source Type: Journal    
DOI: 10.2165/11586150-000000000-00000     Document Type: Article

References (32)

1. Bruijnzeel-Koomen C, Ortolani C, Aas K, et al. Adverse reactions to food. European Academy of Allergology and Clinical Immunology Subcommittee. Allergy 1995;50:623-35
2. Sampson HA. Food allergy. J Allergy Clin Immunol 2003;111: S540-7
3. Sampson HA. Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 1999;103:717-28 (Pubitemid 29297569)
4. Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 1987;79:683-8 (Pubitemid 17087131)
5. Bishop JM, Hill DJ, Hosking CS. Natural history of cow milk allergy: clinical outcome. J Pediatr 1990;116:862-7 (Pubitemid 20201693)
6. Eggleston PA. Prospective studies in the natural history of food allergy. Ann Allergy 1987;59:179-82 (Pubitemid 18006588)
7. Guillet G, Guillet MH. Natural history of sensitizations in atopic dermatitis. A 3-year follow-up in 250 children: food allergy and high risk of respiratory symptoms. Arch Dermatol 1992;128:187-92
8. Hill DJ, Firer MA, Ball G, et al. Natural history of cow's milk allergy in children: immunological outcome over 2 years. Clin Exp Allergy 1993;23:124-31 (Pubitemid 23070560)
9. Host A. Cow's milk protein allergy and intolerance in infancy: some clinical, epidemiological and immunological aspects. Pediatr Allergy Immunol 1994;5:1-36
10. MacDonald TT, Di Sb́tino A. The immunologic basis for gastrointestinal food allergy. Curr Opin Gastroenterol 2009;25:521-6
11. Ohtsuka Y, Sanderson IR, MacDonald TT. Food intolerance: chapter 23. In: Preedy V, Grimble G, Watson R, editors. Nutrition in the infant: problems and practical procedures. London: Greenwich Medical Media Ltd, 2001:247-56
12. Duroudier NP, Tulah AS, Sayers I. Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy 2009;64:823-39
13. Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6-to 14-year old children. JAMA 1998;15:1181-6
14. Global Initiative for Asthma (GINA) [online]. Available from URL: http://www.ginasthma.org [Accessed 2010 Sep. 14]
15. Barnes NC, Pujet JC. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicenter clinical study in asthma. Thorax 1997;52:523-7 (Pubitemid 27298503)
16. Grossman J, Faiferman I, Dubb JW, et al. Results ofthe first U. S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist. J Asthma 1997;34:321-8 (Pubitemid 27365643)
17. Morikẃ A, Nishima S, for the Jṕnese Society of Pediatric Allergy and Clinical Immunology. New Jṕnese pediatric guidelines for the treatment and mńgement of bronchial asthma. Pediatr Int 2007;49:1023-31 (Pubitemid 350197127)
18. Ebisẃ M. Mńgement of food allergy: food allergy mńgement 2005 by National Food Allergy Research Group [in Jṕnese]. Arerugi 2006;55:107-14
19. Nǵta M, Saito K, Kikuchi I, et al. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils. Int Arch Allergy Immunol 2005;137:2-6 (Pubitemid 40868766)
20. Fukushima C, Matsuse H, Hishikẃ Y, et al. Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antafonism. Int Arch Allergy Immunol 2005;136:165-72 (Pubitemid 40463242)
21. Nḱi H, Konno M, Kosuge S, et al. New potent antagonists of leukotrienes C4 and D4: synthesis and structureactivity relationships. J Med Chem 1998;31:84-91
22. Ohshima N, Nǵse H, Koshino T, et al. A functional study on CysLT (1) receptors in human eosinophils. Int Arch Allergy Immunol 2002;129:67-75 (Pubitemid 35316850)
23. Suzuki M, Kato M, Kimura H, et al. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078). J Asthma 2003;40:395-404 (Pubitemid 36859080)
24. Ichiyḿ T, Hasegẃ S, Umeda K, et al. Pranlukast inhibits NF-κB activationin human monocytes/macrophages and T cells. Clin Exp Allergy 2003;33:802-7
25. Tohda Y, Nḱhŕ H, Kubo H, et al. Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma. Clin Exp Allergy 1999;29:1532-6 (Pubitemid 29519284)
26. Tomari S, Matsuse H, Machida I, et al. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen specific tumor necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy 2003;33:795-801 (Pubitemid 36760512)
27. Chen ST, Lu KH, Sun HL, et al. Randomized placebocontrolled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. Pediatr Allergy Immunol 2006;17:49-54
28. Sśki K, Okamoto Y, Yonekura S, et al. Cedar and cyress pollinosis and allergic rhinitis: quality of life effects of early intervention with leukotriene receptor antagonists. Int Arch Allergy Immunol 2009;149:350-8
29. Ohtsuka Y, Shimizu T, Fujii T, et al. Pranlukast regulates tumor growth by attenuating IL-4 production in Kimura's disease. Eur J Pediatr 2004;163:416-7 (Pubitemid 38916382)
30. Attwood SE, Lewis CJ, Bronder CS, et al. Eosinophilic oesophagitis: a novel treatment using montelukast. Gut 2003;52:181-5 (Pubitemid 36115056)
31. Strolin Benedetti M, Whomsley R, Baltes EL. Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations. Expert Opin Drug Metab Toxicol 2005;1:447-71
32. Song DJ, Cho JY, Miller M, et al. Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model. Clin Immunol 2009;131:157-69